Assenagon Asset Management S.A. Roivant Sciences Ltd. Transaction History
Assenagon Asset Management S.A.
- $64.4 Billion
- Q4 2025
A detailed history of Assenagon Asset Management S.A. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 6,937,112 shares of ROIV stock, worth $141 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
6,937,112
Previous 59,764
11507.51%
Holding current value
$141 Million
Previous $904,000
15470.13%
% of portfolio
0.22%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
385Shares Held
444MCall Options Held
6.03MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...